Top Health Tech Companies in Bengaluru (113)
At eClinical Solutions, our goal is to leverage technology to accelerate clinical research and bring life-changing therapies to patients faster. Our industry-leading elluminate® clinical data platform is used by top life sciences companies worldwide to regain control of their data and provide meaningful analytical insights.
eClinical Solutions's Top Stability & Growth Strengths
Strong Revenue Growth: Reported year-over-year software growth in 2024, alongside multi-year increases and net new client additions, indicates sustained commercial momentum. Customer penetration among large pharma is described as expanding across 2024–2025.
Investor Backing & Capital Strength: A majority investment by GI Partners, with Summit Partners remaining a minority investor, is described as supporting further scale, product investment, and global reach. This signals access to resources for continued expansion.
Strong Market Position & Advantage: Independent recognition as the highest-designated Leader in 2024 for life sciences clinical data and analytics platforms, coupled with adoption by numerous top biopharma companies, signals competitive strength in its core segment. Named client expansions further reinforce visibility and impact.
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Schrödinger, Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Total revenue increased to $255.9M in 2025 with software up and drug‑discovery more than doubling, while operating expenses declined year over year. Early 2026 also showed momentum, with first‑half revenue modestly higher and Q2 posting year‑over‑year growth.
Strategic Partnerships: New and expanded agreements—such as Bristol Myers Squibb deploying Bunsen and a July 2026 discovery collaboration with Simcere—broaden platform use and collaboration optionality. The Lilly/Ajax transaction also validated the model and supported a higher 2026 drug‑discovery outlook.
Product Line Growth: The introduction of Bunsen, an agentic AI co‑scientist, expands the software portfolio and is being deployed at scale within BMS. This product push complements growth in ACV and broader platform adoption.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Consolidated revenues increased from $253 billion in 2024 to $270.6 billion in 2025, with quarterly gains such as Q4 2025 up 8% year over year. Growth was led primarily by Optum Rx and supported by steady contributions from Optum Insight.
Market Expansion: Expansion through acquisitions such as Holston Medical Group (August 2025) and Alegeus (July 2026), alongside earlier combinations like Change Healthcare and Atrius Health, broadened capabilities across care, pharmacy, and payments. These moves extend Optum’s platform into adjacent services and operating domains.
Diversified Revenue Streams: A multi-segment model—Rx, Insight, and Health—helps sustain aggregate growth even as individual lines vary, with pharmacy and technology businesses offsetting care-delivery softness. Parent-company commentary continuing to frame Optum as a growth engine and raising 2026 guidance underscores the benefit of this portfolio effect.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Market Expansion: Headcount and footprint are described as rising to more than 15,000 employees across 40-plus offices, alongside concrete new sites in Hyderabad and a completed Chicago buildout—signals of geographic and capacity expansion. These moves indicate confidence in demand across key delivery hubs.
Innovation-Driven Growth: A dedicated Platforms & Products unit, the ZAIDYN portfolio, and AI-agent initiatives point to sustained investment in productized, AI-enabled offerings. Capability-deepening acquisitions (Digital Additive in 2024 and Torrent Consulting in 2025) further strengthen CRM and multi‑cloud life‑sciences solutions.
Strategic Partnerships: An expanded Salesforce collaboration around Agentforce and recognition as Databricks 2025 Life Sciences Partner of the Year suggest momentum in data/AI ecosystems. These alliances position the firm to capture spend where CRM, data, and AI converge in healthcare and life sciences.
Pandorum is a biotechnology company based out of the US and India, working in the field of Tissue Engineering and Regenerative Medicine. With its distinct synergy of life science, engineering and clinical competences, at Pandorum, we have developed a proprietary technology platform which combines therapeutic exosomes with anti-inflammatory, anti-fibrotic properties derived from clinical grade human stem cells and biomaterials with...
YourDOST.com is a platform that allows you to connect with experts to discuss issues related to your personal, professional and academic life. The professionally trained counsellors help you cope with work stress, relationship issues, enhance self-image, and support you in your quest for self-improvement. Connect with YourDOST.com today to understand your emotions, learn self-help techniques, talk to caring experts anytime...
HealthEdge is on a mission to drive a digital revolution in healthcare. We’re connecting health plans, providers, and patients with end-to-end digital technology solutions to support new business models, reduce administrative costs and improve health outcomes. Our growing portfolio of products (HealthRules Payor, Source, GuidingCare, and Wellframe) provides talented and passionate professionals with opportunities to lead change and make a...
_0.jpg)
HealthEdge's Top Stability & Growth Strengths
Strong Market Position & Advantage: HealthRules Payer is positioned as a leader in U.S. payer core administration, supported by repeated “Best in KLAS” mentions and ongoing Gartner recognition in core administrative processing. The company is also described as competing in a top tier with credible differentiation from a connected, modern payer platform.
Investor Backing & Capital Strength: A major ownership transition to Bain Capital and a reported multibillion-dollar transaction value indicate strong investor confidence and available capital for continued expansion. The combination with UST’s HealthProof is framed as a scale move intended to broaden the platform and accelerate growth.
Product Line Growth: The platform has expanded beyond core claims into payment integrity, care management, and member engagement through acquisitions such as The Burgess Group, Altruista Health, and Wellframe. Continued product scaling activity is highlighted through an AWS benchmark announcement intended to support very large plan volumes.
Hi! We are the team behind the popular health tracking app for women – Maya. Our app has touched the lives of 8 million women worldwide and we are just getting started! Maya is on a mission to further women’s health using technology. We are making that happen through a blend of mobile, wearables, analytics and machine learning. Join the...
A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how...
GSK's Top Stability & Growth Strengths
Strong Market Position & Advantage: GSK is positioned as a top-tier global biopharmaceutical company by revenue while showing category leadership in vaccines and HIV, anchored by franchises such as Shingrix and ViiV’s portfolio. Its consistent top-10/12 standing and segment leadership in vaccines, respiratory, and HIV support a stable competitive footing.
Resilient & Sustainable Growth: Revenue and earnings momentum are supported by broad-based growth across Specialty Medicines and continued contributions from Vaccines, alongside reaffirmed multi-year sales ambitions. Guidance for continued turnover and profit expansion indicates an expectation of ongoing, steadier growth rather than a one-off spike.
Healthy Cash Flow: Operating cash generation is described as strong and is being used to fund R&D investment and shareholder returns such as dividends and buybacks. This cash profile supports resilience through investment cycles and potential volatility in specific product areas.
We are the largest mom community in India with over 10 Mn moms visiting our platform every month and over 25 Mn weekly social media reach. We are not just publishers but the best storytellers you will ever come across. There’s a reason our stories have the highest engagement with moms liking, sharing and commenting on our posts every second....
AarogyaAI harnesses the potential of Intelligent Genomics; AI powered genomics to transform healthcare. Our goal is to empower healthcare professionals and decision-makers with data-driven insights by monitoring the real-time evolution of pathogens. This approach enables precision diagnosis, eliminating the need for empirical prescription of drugs. Our focus is particularly on combating Anti-Microbial Resistance and proactively staying ahead of superbugs.
Narayana Health Group is India’s leading healthcare provider and one of the largest hospital groups in the country with a network of 21 hospitals, 5 heart centers, and 19 primary care facilities. The NH group treats over 2.6 Million patients every year from over 78 countries covering 30+ medical specialities. Our Centers of Excellence help in treating Adult & Pediatric patients...
Fortis Healthcare Group is a leading integrated healthcare provider operating across the Asia Pacific region. With more than 20,000 employees and growing, Fortis Helathcare is currently present in Australia, Canada, Hong Kong SAR, India, Mauritius, New Zealand, Singapore, Sri Lanka, UAE, and Vietnam. The hallmark of Fortis Healthcare, distinguishing us from our contemporaries, is the 'patient-centricity' that you will discern all...
At PinkBlue.in, we are building a super-efficient supply-chain for hospital/ clinical supplies! Our vision is to integrate every healthcare product manufacturer and every healthcare institution on to a single platform, and enable them to become smarter, by providing them better data and technology. A by-product of this vision is to enable healthcare institutions to treat materials purchases and inventory management...
Diabetes treatment shouldn't have to be restrictive or stressful. We created sugar.fit to help you reverse diabetes in a simple and sustainable way. Our research-driven treatment plan includes innovative technology, compassionate diabetes experts and personalized plans, which will help you lead a normal life once more.
Founded in 1994 and headquartered in Conshohocken, Pennsylvania, MedRisk was established with a mission to revolutionize physical rehabilitation for workers' compensation patients. Over the last 30 years, the company has evolved into a leading managed care organization dedicated to physical rehabilitation and medical bill review for the casualty claims industry.
furo.fit is a social, employee friendly health & wellness platform targeted to make employees lead a stress-free and healthy lifestyle. For organizations, this means reduced costs on employee health, increased employee productivity and better work culture. Visit https://furo.fit/corporate to know more.
UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. We are 340,000 colleagues in two distinct and complementary businesses working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences. Optum delivers care aided by technology and data,...
UnitedHealth Group's Top Stability & Growth Strengths
Strong Market Position & Advantage: Rankings on the 2026 Fortune 500 and Global 500 reflect industry-leading revenue scale. AM Best identifies the company as the largest public insurer in the U.S./Canada, with Optum Rx among the "Big 3" PBMs.
Diversified Revenue Streams: A vertically integrated model spans UnitedHealthcare and Optum (Health, Insight, Rx), combining insurance, care delivery, pharmacy benefits, and analytics. This breadth supports performance across funding cycles and care settings.
Strong Revenue Growth: Consolidated revenue rose to about $447.6 billion in 2025 from $400.3 billion in 2024, and 2026 has delivered consecutive quarters around $112 billion while full-year earnings guidance was raised.
Every day, millions of patients, caregivers and providers around the world rely on Baxter’s leading portfolio of diagnostic, critical care, nutrition, kidney care, hospital and surgical products and solutions. For 90 years, we’ve been making an impact at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, therapies and...
Baxter International Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: Baxter is a leader in U.S. IV solutions and a top contender in connected-care hospital beds and surgical hemostats, underscoring durable share in core hospital categories. This positioning supports resilience despite category- and region-specific competition.
Product Line Growth: Ongoing updates to infusion technologies and continued launches in injectables and advanced surgery indicate a healthy product refresh cadence. FDA clearances and connected-care enhancements help sustain installed-base momentum.
Future-Ready Strategy: Portfolio reshaping (Kidney Care divestiture) and new leadership focused on execution and continuous improvement signal a sharpened hospital-centric strategy. Deleveraging and supply-chain initiatives aim to improve stability and long-term growth capacity.
